Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy

[Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 2016-12, Vol.114, p.128-143
Hauptverfasser: Cheng, Yu-Ting, Yang, Chun-Chih, Shyur, Lie-Fen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 143
container_issue
container_start_page 128
container_title Pharmacological research
container_volume 114
creator Cheng, Yu-Ting
Yang, Chun-Chih
Shyur, Lie-Fen
description [Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.
doi_str_mv 10.1016/j.phrs.2016.10.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835683008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661816306570</els_id><sourcerecordid>1835683008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</originalsourceid><addsrcrecordid>eNp9kE1OwzAQhS0EoqVwARYoSzYptpM4jsQGVfxJRbCAJbJce0JdNXGxnYruOAQn5CQ4amHJap6e3jzNfAidEjwmmLCLxXg1d35Mo47GGFO6h4YEVywlhLP9XudZyhjhA3Tk_QJjXOUEH6IBLcsqzys-RK9P802wDWijTAvfn18PVndLGUz7ltgPo6NaQ-KDA-8T2eokzCEJXWNd0hjlLLRr42zbQBuSOppKtgpcn3JytTlGB7VcejjZzRF6ubl-ntyl08fb-8nVNFV5RUOqFFEzXagq5zSfFTVmtS5kqXPCMNO6ppTKTPKSUAlZoWnJZkrSmmdQFgyAZiN0vu1dOfvegQ-iMV7BcilbsJ0XhGcF4xnGPEbpNhqP995BLVbONNJtBMGixyoWoscqeqy9F7HGpbNdfzeLrP5WfjnGwOU2APHLtQEnvDIQUWjjQAWhrfmv_wd7kIyh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835683008</pqid></control><display><type>article</type><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</creator><creatorcontrib>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</creatorcontrib><description>[Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2016.10.022</identifier><identifier>PMID: 27794498</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Antineoplastic Agents, Phytogenic - pharmacology ; Antineoplastic Agents, Phytogenic - therapeutic use ; Drug-induced resistance ; Humans ; Inflammation - drug therapy ; Inflammation - immunology ; Inflammation - metabolism ; Inflammation - pathology ; Neoplasms - drug therapy ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - pathology ; Oxidative stress ; Oxidative Stress - drug effects ; Phytomedicines ; Polypharmacology ; Signal Transduction - drug effects ; Tumor microenvironment ; Tumor Microenvironment - drug effects</subject><ispartof>Pharmacological research, 2016-12, Vol.114, p.128-143</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</citedby><cites>FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043661816306570$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27794498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Yu-Ting</creatorcontrib><creatorcontrib>Yang, Chun-Chih</creatorcontrib><creatorcontrib>Shyur, Lie-Fen</creatorcontrib><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</description><subject>Animals</subject><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Antineoplastic Agents, Phytogenic - therapeutic use</subject><subject>Drug-induced resistance</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - immunology</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phytomedicines</subject><subject>Polypharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Tumor microenvironment</subject><subject>Tumor Microenvironment - drug effects</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1OwzAQhS0EoqVwARYoSzYptpM4jsQGVfxJRbCAJbJce0JdNXGxnYruOAQn5CQ4amHJap6e3jzNfAidEjwmmLCLxXg1d35Mo47GGFO6h4YEVywlhLP9XudZyhjhA3Tk_QJjXOUEH6IBLcsqzys-RK9P802wDWijTAvfn18PVndLGUz7ltgPo6NaQ-KDA-8T2eokzCEJXWNd0hjlLLRr42zbQBuSOppKtgpcn3JytTlGB7VcejjZzRF6ubl-ntyl08fb-8nVNFV5RUOqFFEzXagq5zSfFTVmtS5kqXPCMNO6ppTKTPKSUAlZoWnJZkrSmmdQFgyAZiN0vu1dOfvegQ-iMV7BcilbsJ0XhGcF4xnGPEbpNhqP995BLVbONNJtBMGixyoWoscqeqy9F7HGpbNdfzeLrP5WfjnGwOU2APHLtQEnvDIQUWjjQAWhrfmv_wd7kIyh</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Cheng, Yu-Ting</creator><creator>Yang, Chun-Chih</creator><creator>Shyur, Lie-Fen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</title><author>Cheng, Yu-Ting ; Yang, Chun-Chih ; Shyur, Lie-Fen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-cc1cbd5c94824b5f06fd5a7d41606ddf222a3a8712ae35d276bca2f83e756ee23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Antineoplastic Agents, Phytogenic - therapeutic use</topic><topic>Drug-induced resistance</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - immunology</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phytomedicines</topic><topic>Polypharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Tumor microenvironment</topic><topic>Tumor Microenvironment - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Yu-Ting</creatorcontrib><creatorcontrib>Yang, Chun-Chih</creatorcontrib><creatorcontrib>Shyur, Lie-Fen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Yu-Ting</au><au>Yang, Chun-Chih</au><au>Shyur, Lie-Fen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-12</date><risdate>2016</risdate><volume>114</volume><spage>128</spage><epage>143</epage><pages>128-143</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted] In spite of the current advances and achievements in systems biology and translational medicinal research, the current strategies for cancer therapy, such as radiotherapy, targeted therapy, immunotherapy and chemotherapy remain palliative or unsatisfactory due to tumor metastasis or recurrence after surgery/therapy, drug resistance, adverse side effects, and so on. Oxidative stress (OS) plays a critical role in chronic/acute inflammation, carcinogenesis, tumor progression, and tumor invasion/metastasis which is also attributed to the dynamic and complex properties and activities in the tumor microenvironment (TME). Re-educating or reprogramming tumor-associated stromal or immune cells in the TME provides an approach for restoring immune surveillance impaired by disease in cancer patients to increase overall survival and reduce drug resistance. Herbal medicines or plant-derived natural products have historically been a major source of anti-cancer drugs. Delving into the lore of herbal medicine may uncover new leads for anti-cancer drugs. Phytomedicines have been widely documented to directly or indirectly target multiple signaling pathways and networks in cancer cells. A combination of anti-cancer drugs and polypharmacological plant-derived extracts or compounds may offer a significant advantage in sensitizing the efficacy of monotherapy and overcoming drug-induced resistance in cancer patients. This review introduces several phytochemicals and phytoextracts derived from medicinal plants or dietary vegetables that have been studied for their efficacy in preclinical cancer models. We address the underlying modes of action of induction of OS and deregulation of TME-associated stromal cells, mediators and signaling pathways, and reference the related clinical investigations that look at the single or combination use of phytochemicals and phytoextracts to sensitize anti-cancer drug effects and/or overcome drug resistance.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27794498</pmid><doi>10.1016/j.phrs.2016.10.022</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-6618
ispartof Pharmacological research, 2016-12, Vol.114, p.128-143
issn 1043-6618
1096-1186
language eng
recordid cdi_proquest_miscellaneous_1835683008
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antineoplastic Agents, Phytogenic - pharmacology
Antineoplastic Agents, Phytogenic - therapeutic use
Drug-induced resistance
Humans
Inflammation - drug therapy
Inflammation - immunology
Inflammation - metabolism
Inflammation - pathology
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - metabolism
Neoplasms - pathology
Oxidative stress
Oxidative Stress - drug effects
Phytomedicines
Polypharmacology
Signal Transduction - drug effects
Tumor microenvironment
Tumor Microenvironment - drug effects
title Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A31%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phytomedicine%E2%80%94Modulating%20oxidative%20stress%20and%20the%20tumor%20microenvironment%20for%20cancer%20therapy&rft.jtitle=Pharmacological%20research&rft.au=Cheng,%20Yu-Ting&rft.date=2016-12&rft.volume=114&rft.spage=128&rft.epage=143&rft.pages=128-143&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2016.10.022&rft_dat=%3Cproquest_cross%3E1835683008%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835683008&rft_id=info:pmid/27794498&rft_els_id=S1043661816306570&rfr_iscdi=true